$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer 원문보기

Seminars in cancer biology, v.47, 2017년, pp.50 - 56  

Ciccarone, Fabio (Department of Biology, University of Rome ‘Tor Vergata’, via della Ricerca Scientifica, 00133, Rome, Italy) ,  Vegliante, Rolando (Department of Biology, University of Rome ‘Tor Vergata’, via della Ricerca Scientifica, 00133, Rome, Italy) ,  Di Leo, Luca (Department of Biology, University of Rome ‘Tor Vergata’, via della Ricerca Scientifica, 00133, Rome, Italy) ,  Ciriolo, Maria Rosa (Department of Biology, University of Rome ‘Tor Vergata’, via della Ricerca Scientifica, 00133, Rome, Italy)

Abstract AI-Helper 아이콘AI-Helper

Abstract Cancer cells exploit metabolic rearrangements for sustaining their high proliferation rate and energy demand. The TCA cycle is a central metabolic hub necessary for ATP production and for providing precursors used in many biosynthetic pathways. Thus, dysregulation of the TCA cycle flux is ...

주제어

참고문헌 (100)

  1. Carcinogenesis Vegliante 37 233 2016 10.1093/carcin/bgw003 Dehydroepiandrosterone triggers autophagic cell death in human hepatoma cell line HepG2 via JNK-mediated p62/SQSTM1 expression 

  2. J. Neurosci. Res. Chinopoulos 91 1030 2013 10.1002/jnr.23196 Which way does the citric acid cycle turn during hypoxia? The critical role of alpha-ketoglutarate dehydrogenase complex 

  3. J. Biol. Chem. Owen 277 30409 2002 10.1074/jbc.R200006200 The key role of anaplerosis and cataplerosis for citric acid cycle function 

  4. Arch. Physiol. Biochem. Gaster 118 156 2012 10.3109/13813455.2012.656653 Impaired TCA cycle flux in mitochondria in skeletal muscle from type 2 diabetic subjects: marker or maker of the diabetic phenotype 

  5. Cell Nunnari 148 1145 2012 10.1016/j.cell.2012.02.035 Mitochondria: in sickness and in health 

  6. Biochim. Biophys. Acta Benit 1837 1330 2014 10.1016/j.bbabio.2014.03.013 Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling 

  7. PLoS One Chen 9 e115708 2014 10.1371/journal.pone.0115708 Citrate synthase expression affects tumor phenotype and drug resistance in human ovarian carcinoma 

  8. Exp. Cell Res. Anderson 319 1431 2013 10.1016/j.yexcr.2013.02.017 Metabolic changes during ovarian cancer progression as targets for sphingosine treatment 

  9. Pancreas Schlichtholz 30 99 2005 10.1097/01.mpa.0000153326.69816.7d Enhanced citrate synthase activity in human pancreatic cancer 

  10. Sci. Rep. Lin 2 785 2012 10.1038/srep00785 Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy 

  11. Science Vander Heiden 324 1029 2009 10.1126/science.1160809 Understanding the Warburg effect: the metabolic requirements of cell proliferation 

  12. Mol. Cancer Singh 5 14 2006 10.1186/1476-4598-5-14 Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues 

  13. The Prostate Tsui 71 62 2011 10.1002/pros.21222 p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells 

  14. Mol. Cell. Proteomics: MCP Cai 9 2617 2010 10.1074/mcp.M110.000661 A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism 

  15. Med. Oncol. Wang 30 552 2013 10.1007/s12032-013-0552-5 Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer 

  16. Cell Metab. Tohyama 23 663 2016 10.1016/j.cmet.2016.03.001 Glutamine oxidation is indispensable for survival of human pluripotent stem cells 

  17. Int. J Cell Biol. Cardaci 2012 2012 10.1155/2012/161837 TCA cycle defects and cancer: when metabolism tunes redox state 

  18. Blood Abbas 116 2122 2010 10.1182/blood-2009-11-250878 Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value 

  19. J. Clin. Oncol. Marcucci 28 2348 2010 10.1200/JCO.2009.27.3730 IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study 

  20. Eur. J. Human Genet.: EJHG Pasini 16 79 2008 10.1038/sj.ejhg.5201904 Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD 

  21. Proc. Natl. Acad. Sci. U. S. A. Janeway 108 314 2011 10.1073/pnas.1009199108 Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations 

  22. Int. J. Biochem. Cell Biol. Miettinen 53 514 2014 10.1016/j.biocel.2014.05.033 Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review 

  23. Biochim. Biophys. Acta Bardella 1807 1432 2011 10.1016/j.bbabio.2011.07.003 SDH mutations in cancer 

  24. Hum. Pathol. Lehtonen 38 793 2007 10.1016/j.humpath.2006.10.011 Conventional renal cancer in a patient with fumarate hydratase mutation 

  25. Nat. Genet. Tomlinson 30 406 2002 10.1038/ng849 Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer 

  26. Cancer Metabolism Aspuria 2 21 2014 10.1186/2049-3002-2-21 Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism 

  27. Anticancer Res. Chou 36 3983 2016 Isocitrate dehydrogenase 2 dysfunction contributes to 5-hydroxymethylcytosine depletion in gastric cancer cells 

  28. Cancer Lett. Desideri 356 217 2015 10.1016/j.canlet.2014.02.023 Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity 

  29. Hum. Mutat. Bleeker 30 7 2009 10.1002/humu.20937 IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors 

  30. Cancer Metabolism Gaude 2 10 2014 10.1186/2049-3002-2-10 Defects in mitochondrial metabolism and cancer 

  31. J. Clin. Invest. Terunuma 124 398 2014 10.1172/JCI71180 MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis 

  32. Proc. Natl. Acad. Sci. U. S. A. Wise 108 19611 2011 10.1073/pnas.1117773108 Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability 

  33. Nat. Chem. Biol. Ozer 3 144 2007 10.1038/nchembio863 Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one 

  34. EMBO J. Tanimoto 19 4298 2000 10.1093/emboj/19.16.4298 Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein 

  35. J. Clin. Invest. Yang 123 3652 2013 10.1172/JCI67228 Oncometabolites: linking altered metabolism with cancer 

  36. Cancer Cell Isaacs 8 143 2005 10.1016/j.ccr.2005.06.017 HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability 

  37. Cancer Cell Selak 7 77 2005 10.1016/j.ccr.2004.11.022 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase 

  38. Oncogene Zeng 34 4758 2015 10.1038/onc.2014.411 Aberrant IDH3alpha expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis 

  39. Cancer Cell Adam 20 524 2011 10.1016/j.ccr.2011.09.006 Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling 

  40. Nature Koivunen 483 484 2012 10.1038/nature10898 Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation 

  41. Genes. Dev. Sasaki 26 2038 2012 10.1101/gad.198200.112 D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function 

  42. J. Natl. Cancer Inst. Cascon 2015 2015 Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene 

  43. The Prostate Liu 73 1028 2013 10.1002/pros.22650 Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism 

  44. J. Cell. Mol. Med. Lo 19 744 2015 10.1111/jcmm.12388 Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer 

  45. FASEB J. Cooke 17 1195 2003 10.1096/fj.02-0752rev Oxidative DNA damage: mechanisms, mutation, and disease 

  46. Free Radical Biol. Med. Owens 52 160 2012 10.1016/j.freeradbiomed.2011.10.435 Genomic instability induced by mutant succinate dehydrogenase subunit D (SDHD) is mediated by O2(-*) and H2O2 

  47. Cancer Res. Ishii 65 203 2005 10.1158/0008-5472.203.65.1 A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis 

  48. Cell Rep. Wang 13 2353 2015 10.1016/j.celrep.2015.11.029 Oncometabolite D-2-Hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents 

  49. Cell Goldberg 128 635 2007 10.1016/j.cell.2007.02.006 Epigenetics: a landscape takes shape 

  50. Curr. Opin. Genet. Develop. Jeschke 36 16 2016 10.1016/j.gde.2016.01.004 Portraits of TET-mediated DNA hydroxymethylation in cancer 

  51. Aging (Milano) Valentini 8 1896 2016 10.18632/aging.101022 Analysis of the machinery and intermediates of the 5hmC-mediated DNA demethylation pathway in aging on samples from the MARK-AGE Study 

  52. Aging cell Ciccarone 15 755 2016 10.1111/acel.12485 Age-dependent expression of DNMT1 and DNMT3B in PBMCs from a large European population enrolled in the MARK-AGE study 

  53. Oncotarget Ciccarone 6 24333 2015 10.18632/oncotarget.4476 5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme 

  54. Oncotarget Ciccarone 5 10356 2014 10.18632/oncotarget.1905 Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription 

  55. Cancer Res. Klutstein 76 3446 2016 10.1158/0008-5472.CAN-15-3278 DNA methylation in cancer and aging 

  56. Cold Spring Harbor Perspect. Biol. Berger 8 2016 10.1101/cshperspect.a019463 Metabolic signaling to chromatin 

  57. Cancer Cell Xu 19 17 2011 10.1016/j.ccr.2010.12.014 Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases 

  58. Cancer Cell Figueroa 18 553 2010 10.1016/j.ccr.2010.11.015 Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation 

  59. Genes. Dev. Lu 27 1986 2013 10.1101/gad.226753.113 Induction of sarcomas by mutant IDH2 

  60. Cancer Cell Figueroa 17 13 2010 10.1016/j.ccr.2009.11.020 DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia 

  61. Nat. Rev. Cancer Issa 4 988 2004 10.1038/nrc1507 CpG island methylator phenotype in cancer 

  62. Nature Lu 483 474 2012 10.1038/nature10860 IDH mutation impairs histone demethylation and results in a block to cell differentiation 

  63. Genes. Dev. Xiao 26 1326 2012 10.1101/gad.191056.112 Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors 

  64. Hum. Mol. Genet. Smith 16 3136 2007 10.1093/hmg/ddm275 Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma 

  65. Oncotarget Hoekstra 6 38777 2015 10.18632/oncotarget.6091 Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors 

  66. Cancer Cell Letouze 23 739 2013 10.1016/j.ccr.2013.04.018 SDH mutations establish a hypermethylator phenotype in paraganglioma 

  67. Nature Sciacovelli 537 544 2016 10.1038/nature19353 Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition 

  68. Clin. Exp. Immunol. Ashbrook 180 520 2015 10.1111/cei.12591 Citrate modulates lipopolysaccharide-induced monocyte inflammatory responses 

  69. Cancer Res. Zaidi 72 3709 2012 10.1158/0008-5472.CAN-11-4112 ATP-citrate lyase: a key player in cancer metabolism 

  70. Biochim. Biophys. Acta Lettieri Barbato 1845 317 2014 Managing lipid metabolism in proliferating cells: new perspective for metformin usage in cancer therapy 

  71. Science Wellen 324 1076 2009 10.1126/science.1164097 ATP-citrate lyase links cellular metabolism to histone acetylation 

  72. Cell Metab. Lee 20 306 2014 10.1016/j.cmet.2014.06.004 Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation 

  73. Ann. N. Y. Acad. Sci. Reeve 1147 21 2008 10.1196/annals.1427.016 Mitochondrial DNA mutations in disease, aging, and neurodegeneration 

  74. Oncogene Chatterjee 25 4663 2006 10.1038/sj.onc.1209604 Mitochondrial DNA mutations in human cancer 

  75. Biochim. Biophys. Acta Lebedeva 1787 328 2009 10.1016/j.bbabio.2009.01.004 Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis 

  76. Methods Mol. Biol. Singh 471 291 2009 10.1007/978-1-59745-416-2_15 Mitochondrial DNA polymorphism and risk of cancer 

  77. Cancer Res. Guo 71 2978 2011 10.1158/0008-5472.CAN-10-3482 Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer 

  78. eLife Reznik 5 2016 10.7554/eLife.10769 Mitochondrial DNA copy number variation across human cancers 

  79. Proc. Natl. Acad. Sci. U. S. A. Kaufman 97 7772 2000 10.1073/pnas.140063197 In organello formaldehyde crosslinking of proteins to mtDNA: identification of bifunctional proteins 

  80. Nat. Rev. Genet. Chen 6 815 2005 10.1038/nrg1708 The organization and inheritance of the mitochondrial genome 

  81. Mol. Biol. Cell McCammon 14 958 2003 10.1091/mbc.E02-07-0422 Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes 

  82. Trends Biochem. Sci. Shadel 30 294 2005 10.1016/j.tibs.2005.04.007 Mitochondrial DNA, aconitase ‘wraps' it up 

  83. Science Chen 307 714 2005 10.1126/science.1106391 Aconitase couples metabolic regulation to mitochondrial DNA maintenance 

  84. Proc. Natl. Acad. Sci. U. S. A. Chen 104 13738 2007 10.1073/pnas.0703078104 Yeast aconitase binds and provides metabolically coupled protection to mitochondrial DNA 

  85. Mol. Genet. Metab. Sadat 118 28 2016 10.1016/j.ymgme.2016.03.004 Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency 

  86. Free Radical Biol. Med. Panduri 47 750 2009 10.1016/j.freeradbiomed.2009.06.010 Role of mitochondrial hOGG1 and aconitase in oxidant-induced lung epithelial cell apoptosis 

  87. J. Biol. Chem. Kim 289 6165 2014 10.1074/jbc.M113.515130 Mitochondria-targeted Ogg1 and aconitase-2 prevent oxidant-induced mitochondrial DNA damage in alveolar epithelial cells 

  88. Hum. Mol. Genet. Kingsbury 25 3524 2016 10.1093/hmg/ddw195 Cancer-associated isocitrate dehydrogenase mutations induce mitochondrial DNA instability 

  89. Cancer J. Kishton 21 62 2015 10.1097/PPO.0000000000000099 Novel therapeutic targets of tumor metabolism 

  90. Carcinogenesis Simonnet 23 759 2002 10.1093/carcin/23.5.759 Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma 

  91. J. Mol. Endocrinol. Tsui 51 131 2013 10.1530/JME-13-0090 Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells 

  92. Trends Mol. Med. Dang 16 387 2010 10.1016/j.molmed.2010.07.002 IDH mutations in glioma and acute myeloid leukemia 

  93. Blood Cairns 119 1901 2012 10.1182/blood-2011-11-391748 IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma 

  94. Cancer Med. Liu 2 803 2013 10.1002/cam4.149 Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1 

  95. Science Baysal 287 848 2000 10.1126/science.287.5454.848 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma 

  96. J. Urol. Ricketts 188 2063 2012 10.1016/j.juro.2012.08.030 Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer 

  97. Proc. Natl. Acad. Sci. U. S. A. Launonen 98 3387 2001 10.1073/pnas.051633798 Inherited susceptibility to uterine leiomyomas and renal cell cancer 

  98. Hum. Mol. Genet. Castro-Vega 23 2440 2014 10.1093/hmg/ddt639 Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas 

  99. J. Clin. Endocrinol. Metab. Carvajal-Carmona 91 3071 2006 10.1210/jc.2006-0183 Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations 

  100. Cancer Sci. Khalil 98 201 2007 10.1111/j.1349-7006.2007.00374.x Biomarker discovery: a proteomic approach for brain cancer profiling 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로